Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report

ABSTRACT Toxicity from methotrexate overdosing is life threatening condition that requires prompt recognition and early treatment. A 71‐year‐old man from rural Bhutan with diabetes mellitus had symmetrical small joint pain for 3 years associated with early morning stiffness. He was evaluated and dia...

Full description

Saved in:
Bibliographic Details
Main Authors: Thinley Dorji, Tshering Penjor, Sangay Tenzin, Tshering Pedon, Sangay Wangchuck, Sonam Yangchen
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.9638
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846107980270927872
author Thinley Dorji
Tshering Penjor
Sangay Tenzin
Tshering Pedon
Sangay Wangchuck
Sonam Yangchen
author_facet Thinley Dorji
Tshering Penjor
Sangay Tenzin
Tshering Pedon
Sangay Wangchuck
Sonam Yangchen
author_sort Thinley Dorji
collection DOAJ
description ABSTRACT Toxicity from methotrexate overdosing is life threatening condition that requires prompt recognition and early treatment. A 71‐year‐old man from rural Bhutan with diabetes mellitus had symmetrical small joint pain for 3 years associated with early morning stiffness. He was evaluated and diagnosed with seropositive rheumatoid arthritis in a hospital in neighbouring India. He was initiated on Methotrexate and Hydroxychloroquine. The patient had inadvertently taken Methotrexate 10 mg OD for 2 weeks. Following this, he developed painful ulcers on the lips preventing him from swallowing and ulcers around the corona on the penis. He also had intermittent fever with chills. On examination, he had fluid responsive hypotension and pancytopenia without bleeding manifestations. He was managed with intravenous folinic acid, subcutaneous granulocyte colony stimulating factor and intravenous cloxacillin. He had an uneventful recovery and methotrexate has been restarted following adequate patient education. Education of patient and family members is key in preventing medication errors. Early identification and timely management of methotrexate toxicity is key in preventing mortality.
format Article
id doaj-art-1b455efd0b1d409dbd3af5a59d10b4fb
institution Kabale University
issn 2050-0904
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj-art-1b455efd0b1d409dbd3af5a59d10b4fb2024-12-26T06:30:42ZengWileyClinical Case Reports2050-09042024-12-011212n/an/a10.1002/ccr3.9638Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case ReportThinley Dorji0Tshering Penjor1Sangay Tenzin2Tshering Pedon3Sangay Wangchuck4Sonam Yangchen5Department of Internal Medicine Central Regional Referral Hospital Gelephu BhutanDepartment of Internal Medicine Central Regional Referral Hospital Gelephu BhutanDepartment of Internal Medicine Central Regional Referral Hospital Gelephu BhutanSamdrup Jongkhar Hospital Samdrup Jongkhar BhutanDepartment of Internal Medicine Central Regional Referral Hospital Gelephu BhutanDepartment of Rheumatology Kidu Medical Service Centre Thimphu BhutanABSTRACT Toxicity from methotrexate overdosing is life threatening condition that requires prompt recognition and early treatment. A 71‐year‐old man from rural Bhutan with diabetes mellitus had symmetrical small joint pain for 3 years associated with early morning stiffness. He was evaluated and diagnosed with seropositive rheumatoid arthritis in a hospital in neighbouring India. He was initiated on Methotrexate and Hydroxychloroquine. The patient had inadvertently taken Methotrexate 10 mg OD for 2 weeks. Following this, he developed painful ulcers on the lips preventing him from swallowing and ulcers around the corona on the penis. He also had intermittent fever with chills. On examination, he had fluid responsive hypotension and pancytopenia without bleeding manifestations. He was managed with intravenous folinic acid, subcutaneous granulocyte colony stimulating factor and intravenous cloxacillin. He had an uneventful recovery and methotrexate has been restarted following adequate patient education. Education of patient and family members is key in preventing medication errors. Early identification and timely management of methotrexate toxicity is key in preventing mortality.https://doi.org/10.1002/ccr3.9638adverse drug eventantidotehealth literacyleucovorinmedication errors
spellingShingle Thinley Dorji
Tshering Penjor
Sangay Tenzin
Tshering Pedon
Sangay Wangchuck
Sonam Yangchen
Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
Clinical Case Reports
adverse drug event
antidote
health literacy
leucovorin
medication errors
title Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
title_full Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
title_fullStr Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
title_full_unstemmed Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
title_short Mucocutaneous Ulcerations and Pancytopenia Secondary to Methotrexate Toxicity in a Patient With Rheumatoid Arthritis: A Case Report
title_sort mucocutaneous ulcerations and pancytopenia secondary to methotrexate toxicity in a patient with rheumatoid arthritis a case report
topic adverse drug event
antidote
health literacy
leucovorin
medication errors
url https://doi.org/10.1002/ccr3.9638
work_keys_str_mv AT thinleydorji mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport
AT tsheringpenjor mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport
AT sangaytenzin mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport
AT tsheringpedon mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport
AT sangaywangchuck mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport
AT sonamyangchen mucocutaneousulcerationsandpancytopeniasecondarytomethotrexatetoxicityinapatientwithrheumatoidarthritisacasereport